Clinical Efficacy of Dapagliflozin in the Treatment of Patients with Diabetic Nephropathy and Its Effect on Proteinuria Level
Diabetes, Metabolic Syndrome and Obesity · 2023-07 · Volume 16 · 2167-2175
DOI: 10.2147/dmso.s421579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2023-07. Verfasst von Ze-Jun Jin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Anhui Wannan Rehabilitation Hospital, Wuhu, Anhui, People's Republic of China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
This study aimed to analyze the clinical efficacy of dapagliflozin in the treatment of diabetic kidney disease and its impact on proteinuria levels in patients.
Methods
Retrospective analysis of medical records of 176 patients with diabetic kidney disease treated at our hospital from January 2020 to January 2022. According to the different treatment methods, the patients were divided into a control group (n=88) receiving enalapril maleate treatment and an observation group (n=88) receiving dapagliflozin treatment. The clinical treatment effects, blood glucose levels, renal function indicators, inflammation factor indicators, and adverse reactions were compared between the two groups.
Results
The total effective rate of treatment (97.73%) in the observation group was significantly higher than that (79.55%) in the control group (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Anhui Wannan Rehabilitation Hospital, Wuhu, Anhui, People's Republic of China.
Zitieren
APA
Jin, Z. J., & Wang, G. Z. (2023). Clinical Efficacy of Dapagliflozin in the Treatment of Patients with Diabetic Nephropathy and Its Effect on Proteinuria Level. Diabetes, Metabolic Syndrome and Obesity, Volume 16, 2167-2175. https://doi.org/10.2147/dmso.s421579
Vancouver
Jin ZJ, Wang GZ. Clinical Efficacy of Dapagliflozin in the Treatment of Patients with Diabetic Nephropathy and Its Effect on Proteinuria Level. Diabetes, Metabolic Syndrome and Obesity. 2023;Volume 16:2167-2175. doi:10.2147/dmso.s421579
BibTeX
@article{Jin2023,
author = {Jin, Ze-Jun and Wang, Gen-Zhen},
title = {Clinical Efficacy of Dapagliflozin in the Treatment of Patients with Diabetic Nephropathy and Its Effect on Proteinuria Level},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2023},
volume = {Volume 16},
pages = {2167--2175},
doi = {10.2147/dmso.s421579}
}
EUVIMED